Brian Schwartz, MD
Interventional Cardiology · Centerville, OHNPI 1255315453
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $78,762 of the $114,940 with a category attached, or 68.5%. Medtronic accounts for 84.1% of it on its own, with 8 other manufacturers making up the rest. Among interventional cardiology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 173 payments — averaging $664.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$97K
- Abbott$17K
- Boston Scientific$1K
- AstraZeneca$210
- Abiomed$125
- Edwards Lifesciences$39
- plus $36 from 3 others
Across 72 payments — averaging $2657.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$139K
- Boston Scientific$44K
- Siemens Medical Solutions USA, Inc.$8K
What the payments were for
- Consulting fees$12,50011%
- Speaking & faculty fees$78,76269%
- Travel & lodging$20,35918%
- Food & beverage$3,2953%
- Education$240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 106 | $96,662 |
| Abbott | 33 | $16,535 |
| Boston Scientific | 18 | $1,334 |
| AstraZeneca | 11 | $210 |
| Abiomed | 1 | $125 |
| Edwards Lifesciences | 1 | $39 |
| United Therapeutics Corporation | 1 | $13 |
| Chiesi USA, Inc. | 1 | $12 |
| Cardiovascular Systems Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CoreValve Evolut$49,038
- COREVALVE EVOLUT R$46,208
- AMPLATZER AMULET$14,253
- GENERAL - THERAPIES$814
- MitraClip$272
- NAVITOR$111
How this compares
$114,940 in reported general payments places this provider in the 90th percentile of 256 interventional cardiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 17 | $13,103 |
| JardianceEmpagliflozin | 11 | $8,838 |
| ClopidogrelClopidogrel Bisulfate | 80 | $649 |
| Metoprolol Succinate | 19 | $196 |
| Atorvastatin Calcium | 16 | $139 |
| Rosuvastatin Calcium | 12 | $103 |
| Losartan Potassium | 13 | $46 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Centerville
- Gary FishbeinCenterville$69K
- Ziwar KarabatakCenterville$22K
- Gary AnselColumbus$3.3M
- John CheathamColumbus$1.4M
- Carlos Sanchez SotoColumbus$1.1M
- Steven YakubovColumbus$907K
- Timothy HenryCincinnati$605K
- Mitchell SilverColumbus$562K
- John PhillipsColumbus$410K
- John CorlCincinnati$390K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.